Astrotech Reports Second Quarter of Fiscal Year 2019 Financial Results

AUSTIN, Texas–(BUSINESS WIRE)–lt;a href=”https://twitter.com/search?q=%24ASTC&src=ctag” target=”_blank”gt;$ASTClt;/agt;–Astrotech Corporation (NASDAQ: ASTC) reported its financial results for
the second quarter of fiscal year 2019 ended December 31, 2018.
The second quarter was a pivotal quarter for Astrotech’s 1st
Detect subsidiary, which announced on December 12, 2018 that its TRACER
1000 passed the rigorous European Civil Aviation Conference (ECAC)
Common Evaluation Process (CEP) tests for airport checkpoint screening
of passengers. Subsequent to the quarter-end, on January 7, 2019, the
Company announced that the TRACER 1000 also passed the CEP tests for
airport cargo screening. Official ECAC Certification is expected in the
near-term, at which point, the Company can begin selling the TRACER 1000
to international airports.
“We are excited to have introduced our revolutionary new product, the
TRACER 1000, this quarter as the best solution available to overcome the
high false alarm problems with the currently used ion mobility
spectrometry technology. Our mass spectrometry technology delivers a
valuable near-zero false alarm rate that has the potential to earn
airports and airlines hundreds of millions in worldwide savings while
making airways safer and moving passengers through the security lanes
more efficiently,” stated Thomas B. Pickens III, Chairman and CEO of
Astrotech.
Second Quarter Fiscal Year 2019 Financial Highlights
Management continues efforts to optimize our resources while reducing
cost and adding financial flexibility.
-
Operating expenses decreased $1.0 million, or 31%, during the second
quarter of fiscal 2019, compared to the second quarter of fiscal 2018,
due to an ongoing emphasis on cost reduction. -
Our monthly cash burn for this quarter was reduced to $705 thousand, a
22% reduction from our run rate in fiscal year 2018. -
On October 9, 2018, Astrotech completed a $3 million private
investment from its Chairman and CEO and another long-term investor. - Astrotech Corporation had no debt at December 31, 2018.
About Astrotech
Astrotech (NASDAQ: ASTC) is a science and technology development and
commercialization company that launches, manages, and builds scalable
companies based on innovative technology in order to maximize
shareholder value. 1st
Detect develops, manufactures, and sells chemical analyzers for
use in the security, defense, healthcare, and environmental markets. Astral
Images sells film-to-digital image enhancement, defect removal,
color correction, and post processing software, providing economically
feasible conversion of film to the new 4K ultra-high definition (UHD),
high-dynamic range (HDR) format. Astrotech is headquartered in Austin,
Texas. For information, please visit www.astrotechcorp.com.
This press release contains forward-looking statements that are made
pursuant to the Safe Harbor provisions of the Private Securities
Litigation Reform Act of 1995. Such forward-looking statements are
subject to risks, trends, and uncertainties that could cause actual
results to be materially different from the forward-looking statement.
These factors include, but are not limited to, the Company’s use of
proceeds from the private placement transaction, whether we can
successfully develop our proprietary technologies and whether the market
will accept our products and services, as well as other risk factors and
business considerations described in the Company’s Securities and
Exchange Commission filings including the annual report on Form 10-K for
the fiscal year ended June 30, 2018. Any forward-looking statements in
this document should be evaluated in light of these important risk
factors. In addition, any forward-looking statements included in this
press release represent the Company’s views only as of the date of its
publication and should not be relied upon as representing its views as
of any subsequent date. The Company assumes no obligation to update
these forward-looking statements.
ASTROTECH CORPORATION AND SUBSIDIARIES | |||||||||||||||||||||
Condensed Consolidated Statements of Operations and Comprehensive Loss |
|||||||||||||||||||||
(In thousands, except per share data) |
|||||||||||||||||||||
(Unaudited) |
|||||||||||||||||||||
Three Months Ended |
Six Months Ended |
||||||||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||||||||
Revenue | $ | 7 | $ | 41 | $ | 40 | $ | 41 | |||||||||||||
Cost of revenue | — | 24 | 11 | 24 | |||||||||||||||||
Gross profit | 7 | 17 | 29 | 17 | |||||||||||||||||
Operating expenses: | |||||||||||||||||||||
Selling, general and administrative | 1,286 | 1,602 | 2,430 | 3,034 | |||||||||||||||||
Research and development | 897 | 1,582 | 2,000 | 3,226 | |||||||||||||||||
Total operating expenses | 2,183 | 3,184 | 4,430 | 6,260 | |||||||||||||||||
Loss from operations | (2,176 | ) | (3,167 | ) | (4,401 | ) | (6,243 | ) | |||||||||||||
Interest and other income, net | 16 | 30 | 3 | 100 | |||||||||||||||||
Loss before income taxes | (2,160 | ) | (3,137 | ) | (4,398 | ) | (6,143 | ) | |||||||||||||
Income tax benefit | — | — | — | — | |||||||||||||||||
Net loss | $ | (2,160 | ) | $ | (3,137 | ) | $ | (4,398 | ) | $ | (6,143 | ) | |||||||||
Weighted average common shares outstanding: | |||||||||||||||||||||
Basic and diluted | 4,678 | 4,060 | 4,374 | 4,059 | |||||||||||||||||
Basic and diluted net loss per common share: | |||||||||||||||||||||
Net loss | $ | (0.46 | ) | $ | (0.77 | ) | $ | (1.01 | ) | $ | (1.51 | ) | |||||||||
Other comprehensive loss, net of tax: | |||||||||||||||||||||
Net loss | $ | (2,160 | ) | $ | (3,137 | ) | $ | (4,398 | ) | $ | (6,143 | ) | |||||||||
Available-for-sale securities: | |||||||||||||||||||||
Net unrealized gain | — | (36 | ) | — | (35 | ) | |||||||||||||||
Reclassification adjustment for realized loss | — | 33 | 31 | 34 | |||||||||||||||||
Total comprehensive loss | $ | (2,160 | ) | $ | (3,140 | ) | $ | (4,367 | ) | $ | (6,144 | ) | |||||||||
ASTROTECH CORPORATION AND SUBSIDIARIES | ||||||||||
Condensed Consolidated Balance Sheets | ||||||||||
(In thousands, except share data) |
||||||||||
(Unaudited) |
||||||||||
December 31, |
June 30, |
|||||||||
Assets | ||||||||||
Current assets | ||||||||||
Cash and cash equivalents | $ | 2,846 | $ | 552 | ||||||
Short-term investments | — | 3,551 | ||||||||
Accounts receivable, net of allowance | 8 | 12 | ||||||||
Prepaid expenses and other current assets | 236 | 161 | ||||||||
Total current assets | 3,090 | 4,276 | ||||||||
Property and equipment, net | 595 | 733 | ||||||||
Long-term investments | — | 50 | ||||||||
Other assets, net | 81 | 81 | ||||||||
Total assets | $ | 3,766 | $ | 5,140 | ||||||
Liabilities and stockholders’ equity | ||||||||||
Current liabilities | ||||||||||
Accounts payable | $ | 219 | $ | 112 | ||||||
Payroll-related accruals | 392 | 412 | ||||||||
Accrued liabilities and other | 336 | 434 | ||||||||
Income tax payable | 2 | 2 | ||||||||
Total current liabilities | 949 | 960 | ||||||||
Other liabilities | 167 | 188 | ||||||||
Total liabilities | 1,116 | 1,148 | ||||||||
Commitments and contingencies | ||||||||||
Stockholders’ equity | ||||||||||
Preferred stock, $0.001 par value, convertible, 2,500,000 shares authorized; no shares issued and outstanding at December 31, 2018 and June 30, 2018, respectively |
— | — | ||||||||
Common stock, $0.001 par value, 15,000,000 shares authorized; 5,970,885 and 4,496,873 shares issued at December 31, 2018 and June 30, 2018, respectively; 5,570,969 and 4,097,346 shares outstanding at December 31, 2018 and June 30, 2018, respectively |
190,584 | 190,570 | ||||||||
Treasury stock, 399,916 and 399,527 shares at cost at December 31, 2018 and June 30, 2018, respectively |
(4,129 | ) | (4,128 | ) | ||||||
Additional paid-in capital | 4,757 | 1,745 | ||||||||
Accumulated deficit | (188,562 | ) | (184,164 | ) | ||||||
Accumulated other comprehensive loss | — | (31 | ) | |||||||
Total stockholders’ equity | 2,650 | 3,992 | ||||||||
Total liabilities and stockholders’ equity | $ | 3,766 | $ | 5,140 | ||||||
Contacts
Eric Stober, Chief Financial Officer, Astrotech Corporation, (512)
485-9530